Joshua D Brandstadter
Overview
Explore the profile of Joshua D Brandstadter including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
227
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pierson S, Brandstadter J, Torigian D, Bagg A, Lechowicz M, Alapat MD D, et al.
Blood Adv
. 2025 Feb;
PMID: 39951615
Castleman disease (CD) describes a group of rare lymphoproliferative disorders that exhibit a wide range of symptomatology and degree of lymphadenopathy, particularly across the two forms of CD with unknown...
2.
Allman A, Gaudette B, Kelly S, Alouche N, Carrington L, Perkey E, et al.
Immunity
. 2024 Dec;
58(1):143-161.e8.
PMID: 39731910
Innate-like splenic marginal zone (MZ) B (MZB) cells play unique roles in immunity due to their rapid responsiveness to blood-borne microbes. How MZB cells integrate cell-extrinsic and -intrinsic processes to...
3.
Shyamsundar S, Pierson S, Connolly C, Teles M, Segev D, Werbel W, et al.
Blood Neoplasia
. 2024 Jul;
1(1).
PMID: 39044861
The coronavirus disease of 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has resulted in increased morbidity and mortality in patients with impaired immunity, hematologic malignancies,...
4.
Sarmiento Bustamante M, Pierson S, Ren Y, Bagg A, Brandstadter J, Srkalovic G, et al.
Haematologica
. 2024 Jan;
109(7):2196-2206.
PMID: 38205523
Idiopathic multicentric Castleman disease (iMCD) is a rare hematologic disorder with heterogeneous presentations ranging from moderate constitutional symptoms to life-threatening multiorgan system involvement. There are vastly different clinical subtypes, with...
5.
Rubenstein A, Pierson S, Shyamsundar S, Sarmiento Bustamante M, Gonzalez M, Milller I, et al.
Br J Haematol
. 2024 Jan;
204(3):921-930.
PMID: 38168727
Idiopathic multicentric Castleman disease (iMCD) is a rare haematological disorder characterized by generalized lymphadenopathy with atypical histopathological features and systemic inflammation caused by a cytokine storm involving interleukin-6 (IL-6). Three...
6.
Mango N, Pierson S, Sarmiento Bustamante M, Brandstadter J, van Rhee F, Fajgenbaum D
Am J Hematol
. 2023 Oct;
99(1):E15-E18.
PMID: 37867418
No abstract available.
7.
Pierson S, Lim M, Srkalovic G, Brandstadter J, Sarmiento Bustamante M, Shyamsundar S, et al.
Blood Adv
. 2023 Sep;
7(21):6652-6664.
PMID: 37656441
Idiopathic multicentric Castleman disease (iMCD) is a rare hematologic disorder with an unknown etiology. Clinical presentation is heterogeneous, ranging from mild constitutional symptoms with lymphadenopathy to life-threatening multiorgan dysfunction. International,...
8.
Sarmiento Bustamante M, Shyamsundar S, Coren F, Bagg A, Srkalovic G, Alapat D, et al.
Am J Hematol
. 2023 Aug;
98(11):E334-E337.
PMID: 37635628
No abstract available.
9.
Brandstadter J, Outen R, Maillard I
J Clin Invest
. 2023 Aug;
133(15).
PMID: 37526083
Allogeneic hematopoietic cell transplantation can cure patients with high-risk leukemia through graft-versus-leukemia (GVL) effects, the process by which malignant leukemic cells are cleared by donor-derived immune cells from the graft....
10.
Brandstadter J, De Martin A, Lytge M, Ferreira A, Gaudette B, Stanossek Y, et al.
Eur J Immunol
. 2023 Jun;
53(9):e2250362.
PMID: 37366295
Nonhematopoietic lymph node stromal cells (LNSCs) regulate lymphocyte trafficking, survival, and function for key roles in host defense, autoimmunity, alloimmunity, and lymphoproliferative disorders. However, the study of LNSCs in human...